ABSTRACT NUMBER: ESOC2026A1048 POST-THROMBOLYSIS LIPOPROTEIN(A) AND THE RISK OF SYMPTOMATIC HEMORRHAGIC TRANSFORMATION IN ACUTE ISCHEMIC STROKE
Mi Sun Oh, Byung-Chul Lee, Chaery Jeon · 2026
Read ABSTRACT NUMBER: ESOC2026A1048 POST-THROMBOLYSIS LIPOPROTEIN(A) AND THE RISK OF SYMPTOMATIC HEMORRHAGIC TRANSFORMATION IN ACUTE ISCHEMIC STROKE by Mi Sun Oh, Byung-Chul Lee, Chaery Jeon (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13146314.txt.
Description
Mi Sun Oh and co-authors report a 2026 conference study on a fat-carrying blood particle and bleeding risk after clot-busting drug care. The particle is known to feed vessel disease and clotting. Whether its level tracks severe bleeding after the drug was unclear.
Records covered more than three hundred patients treated at one center from 2020 to 2025. Blood levels were checked within a day of drug care. Symptom-causing bleeding struck about one in six patients by one rule set. Higher particle levels meant higher bleeding odds at each step up. Patients in the top third of levels faced about six times the odds of those in the lowest third.
Catalog record
| CREATOR | Mi Sun Oh, Byung-Chul Lee, Chaery Jeon |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |